In a similar single-center study, Zhou et al. [14] reported that the most common mutations in AML-MR were TP53, RUNX1 and ASXL1. Our results are consistent with these findings; ASXL1 and TP53 mutations were most frequently found in patients with AML-MR. This evidence concerns the gene TP53 and acute myeloid leukemia.